Intranasal Insulin for Posttraumatic Stress Disorder
ConditionPTSD
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age21-65
SponsorVA Connecticut Healthcare System
About this trial
To evaluate if intranasal insulin is effective in reducing PTSD symptoms.
Eligibility criteria
Qualifiers
Male or female, 21-65 years old
Current PTSD
Able to provide written informed consent
Disqualifiers
Unstable medical condition, clinically determined by a physician
Diabetes requiring insulin or oral hypoglycemic agents
Moderate-severe traumatic brain injury
Current psychotic disorder, bipolar disorder, cognitive disorder in the past 12 months
Trial design
Treatments tested in this trial
- Intranasal insulin
- Placebo
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov